HIV/AIDS

Extensively drug-resistant tuberculosis (XDR TB) outbreaks have been reported in South Africa, and strains have been identified on 6 continents. Dr. Peter Cegielski, team leader for drug-resistant TB with the Division of Tuberculosis Elimination at CDC, comments on a multinational team's report on this emerging global public health threat.

This fact sheet includes helpful hints on pediatric medicine administration if a child has difficulty swallowing pills or capsules.

This information sheet discusses physician prescription of sterile syringes to injection drug users (IDUs) who continue to inject, in order to prevent the acquisition and transmission of HIV and other blood-borne diseases. Physician prescription of sterile syringes will not only help IDUs receive sterile syringes legally, but also can create links to other health care and social services that IDUs would not normally seek out. The example is given of a progam in Rhode Island that is examining the feasiblity of physician prescription in a community setting.

This information sheet discusses the prevalence of HIV/AIDS among women. The sheet presents statistics on the number of women living with HIV/AIDS and notes that the majority of new AIDS cases are African American women and Latinas. Reasons for the higher proportion of women contracting HIV are discussed including the lack of an effective female-controlled method of HIV prevention, women are at-risk because they may not be aware of the high-risk behavior of their partners, and HIV is transmitted eight times more efficiently from men to women.

This information sheet discusses the impact of HIV/AIDS on communities of color. It reports that people of color have been disproportionately affected by HIV/AIDS and represent the highest number of new AIDS cases and the largest number of people living with AIDS in the US. The information sheet discusses the reasons behind these statistics and some of the programs that have been developed in response.

This monograph seeks to build practical skills for nongovernmental organizations (NGOs), community-based organizations (CBOs), and groups of people living with HIV that are responding to HIV/AIDS in developing countries. It is designed to help NGOs, CBOs, and PLWHA groups improve the quality of their work on HIV/AIDS-related treatment. Chapter one helps groups understand key terms, links between HIV/AIDS-related treatment and HIV prevention, factors affecting access to HIV/AIDS-related treatment, and barriers to treatment access. Chapter two focuses on the foundations of treatment.

This monograph is a workbook that describes ways in which religious leaders can respond to HIV/AIDS epidemic. The monograph explains why religious leaders are uniquely suited to the task of speaking out in the fight to stop HIV/AIDS. It provides information on HIV/AIDS such as HIV transmission, how HIV/AIDS affects the body, how it affects children and young people, and HIV prevention. It contains suggestions and examples of activities and approaches that religious leaders can use to fight the HIV/AIDS epidemic and to serve and support those affected by it, particularly young people.

General information about what is tuberculosis (TB), the difference between LTBI and active TB, and how to get tested for TB.

This monograph is a toolkit for planning and implementing antiretroviral (ARV) treatment programs in resource-limited settings by providing technical guidance on planning treatment programs. It lists the goals of an ARV treatment program as reducing illnesses and death due to HIV/AIDS, providing safe and effective treatment, working towards providing universal access to treatment, making the best possible use of resources, and integrating ARV treatment with other public health resources.

This serial is a newsletter that reports on the corporate philantropic response to HIV in the United States and globally. This issue discusses the World Economic Forum's Global Health Initiative (GHI), the Henry J. Kaiser Family Foundation and Viacom's 'Know HIV/AIDS' global media campaign to combat HIV/AIDS, the Design Industries Fighting AIDS (DIFFA) program, the ways in which companies are helping to fund the fight against HIV/AIDS, and a report on the Global Business Coalition on HIV/AIDS (GBC).